Format

Send to

Choose Destination
Nat Rev Drug Discov. 2015 Jul;14(7):443-4. doi: 10.1038/nrd4664.

Assessing the relative efficacy of new drugs: an emerging opportunity.

Author information

1
European Medicines Agency, 30 Churchill Place, Canary Wharf, London E14 5EU, UK.
2
Division of Pharmacoepidemiology, Department of Medicine, Brigham and Womens Hospital and Harvard Medical School, 1 Brigham Circle, Boston, Massachusetts 02120, USA.

Abstract

The increasing availability of individual-level data from clinical trials could allow the relative efficacy of new drugs to be assessed in a robust, cost-effective and timely way.

PMID:
26129789
DOI:
10.1038/nrd4664
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center